Geriatric assessment and anticoagulatlon in elderly patients with chronic atrial fibrillation [10]

Archives of Internal Medicine

Volumn 160, Issue 15, 2000, Pages 2402-

  Bellelli, G ^a   Rozzini, R ^a   Barbisoni, P ^a   Sabatini, T ^a   Trabucchi, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; WARFARIN;

ADVERSE DRUG REACTION; AGED; ANTICOAGULATION; CHRONICITY; DRUG INDICATION; DRUG MONITORING; DRUG USE; FEMALE; FOLLOW UP; GERIATRIC CARE; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME; BRAIN EMBOLISM; GERIATRIC ASSESSMENT; NOTE;

AGED; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; GERIATRIC ASSESSMENT; HUMANS; INTRACRANIAL EMBOLISM; PATIENT COMPLIANCE; WARFARIN;

EID: 0034726374     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.15.2402     Document Type: Letter

References (4)

1. Why do patients with atrial fibrillation not receive warfarin?
2. Adjusted-dose warfarin versus low-intensity fixed dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial
3. Prospective identification of atrial fibrillation patients at low risk of stroke during treatment with aspirin: The SPAF-III Aspirin Low-Risk Cohort Study
4. Patients with nonvascular fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study